Absci Corporation ABSI
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Absci Corporation is a clinical-stage biopharmaceutical company that specializes in using generative artificial intelligence to design and create biologic drugs. The company operates a data-first drug creation platform that integrates AI models with scalable wet lab technologies to discover, optimize, and produce thera…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees140
TickerABSI
Statistics
Market Cap$1.15B
Revenue (TTM)$2.8M
Net Income-$115.2M
Net Margin-4113.7%
EPS$-0.84
P/E-8.10
P/S552.80
P/B5.88
EV/EBITDA-7.67
ROE-63.9%
Dividend Yield—
Price$7.42
Data: Twelve Data · Revenue = mcap / P/S